The trademark application MALLOZEN was filed by EQL Pharma AB, a corporation established under the laws of the Kingdom of Sweden (the "Applicant"). The application was published for oppositions on April 5, 2022, and it was registered by office on July 13, 2022 without any oppositions.
It was designated 'Basic Application' for International Application 1659559 at the World Intellectual Property Organization (WIPO).
The application was filed in Swedish (English was selected as the second language).
Change of name and professional address of the trademark registration was recorded on July 14, 2022. International trade mark of the trademark registration was recorded on July 14, 2022.